Drug intelligence / Profile preview

Helium and Sevoflurane

Development stage
Unknown
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Inhalation
01

Overview

The combination of helium and sevoflurane is used in anesthesia, particularly for patients with upper airway obstruction. Helium is an inert gas that, when mixed with oxygen as a carrier gas for sevoflurane (a volatile anesthetic agent), can improve gas exchange and reduce airway resistance during anesthesia. ## Medical Applications Helium-sevoflurane combinations are particularly beneficial in: 1. Anesthesia for upper airway obstruction 2. Improving gas exchange during spontaneous ventilation 3. Reducing respiratory effort in patients with compromised airways Studies have shown that helium has negligible effects on the output of sevoflurane vaporizers, making it a safe carrier gas alternative to standard oxygen or air mixtures[1][4]. The presence of helium in the carrier gas does not adversely affect the performance of sevoflurane vaporizers, with changes in output remaining within ±10% of baseline even with varying carrier gas flow rates[1]. ## Physiological Benefits When helium is used with sevoflurane anesthesia: - It decreases audible inspiratory stridor - Improves gas exchange - Decreases respiratory rate - Reduces suprasternal/intercostal retractions - Decreases transcutaneous CO₂ levels[2] These benefits stem from helium's physical properties - it has lower density and viscosity compared to oxygen or air, which reduces the work of breathing through narrowed airways[8][9]. ## Safety Profile Helium is categorized as a "non-immobilizer" - a gas that does not induce anesthesia but may have other biological effects[8]. Unlike other noble gases such as xenon, helium lacks anesthetic properties and has no significant hemodynamic side effects, making it suitable for use in patients with respiratory difficulties during anesthesia[6][8]. The combination of helium and sevoflurane has been tested in clinical settings and found to be safe for use with standard vaporizers like Blease Datum and Drager Vapor 19.3[1].

Other names
Helium-sevoflurane combinations
02

Targets

NaV alpha (Voltage-gated sodium channel alpha subunit family)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on Helium and Sevoflurane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helium and Sevoflurane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call